About Surrozen
Surrozen is a company based in San Francisco (United States) founded in 2016.. Surrozen has raised $133 million across 5 funding rounds from investors including RA Capital, Hartford HealthCare and The Column Group. The company has 41 employees as of December 31, 2024. Surrozen offers products and services including Wnt Biology Platform and SWAP/SWEETS. Surrozen operates in a competitive market with competitors including Novartis, Catalent, Biotage, Curia and AmplifyBio, among others.
- Headquarter San Francisco, United States
- Employees 41 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Surrozen, Inc.
-
Annual Revenue
$10.65 M0as on Dec 31, 2024
-
Net Profit
$-63.56 M-47.68as on Dec 31, 2024
-
EBITDA
$-24.1 M41.39as on Dec 31, 2024
-
Total Equity Funding
$133 M (USD)
in 5 rounds
-
Latest Funding Round
$175 M (USD), Post-IPO
Mar 24, 2025
-
Investors
RA Capital
& 13 more
-
Employee Count
41
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Surrozen
Surrozen is a publicly listed company on the NASDAQ with ticker symbol SRZN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Surrozen
Surrozen offers a comprehensive portfolio of products and services, including Wnt Biology Platform and SWAP/SWEETS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for unlocking body's regenerative power to treat injuries and diseases
Technology for advancing treatments in regenerative medicine and disease pipelines
Unlock access to complete
Unlock access to complete
Funding Insights of Surrozen
Surrozen has successfully raised a total of $133M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $175 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $175.0M
-
First Round
First Round
(15 Feb 2017)
- Investors Count 14
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Post-IPO - Surrozen | Valuation | Venrock | |
| Apr, 2024 | Amount | Post-IPO - Surrozen | Valuation |
investors |
|
| Jun, 2020 | Amount | Series C - Surrozen | Valuation | TCG , Horizons Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Surrozen
Surrozen has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include RA Capital, Hartford HealthCare and The Column Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Early-stage investments in US life science startups are focused on.
|
Founded Year | Domain | Location | |
|
Access Biotechnology is engaged in investing in transformative biopharma therapies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Surrozen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Surrozen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Surrozen Comparisons
Competitors of Surrozen
Surrozen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Biotage, Curia and AmplifyBio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
CDMO offering drug and biologics development services
|
|
| domain | founded_year | HQ Location |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Provides contract research, development, and manufacturing services for biologic drugs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Surrozen
Frequently Asked Questions about Surrozen
When was Surrozen founded?
Surrozen was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Surrozen located?
Surrozen is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Surrozen a funded company?
Surrozen is a funded company, having raised a total of $133M across 5 funding rounds to date. The company's 1st funding round was a Series C of $50M, raised on Feb 15, 2017.
How many employees does Surrozen have?
As of Dec 31, 2024, the latest employee count at Surrozen is 41.
What is the annual revenue of Surrozen?
Annual revenue of Surrozen is $10.65M as on Dec 31, 2024.
What does Surrozen do?
Surrozen was founded in 2016 and is headquartered in San Francisco, United States. Protein therapeutics targeting the Wnt pathway are discovered and developed to support tissue repair and regeneration. A pipeline of selective agonists is constructed to enable in situ regeneration across various tissues. Roles of Wnt proteins in stem cell maintenance and developmental processes are leveraged within the biotechnology sector.
Who are the top competitors of Surrozen?
What products or services does Surrozen offer?
Surrozen offers Wnt Biology Platform and SWAP/SWEETS.
Is Surrozen publicly traded?
Yes, Surrozen is publicly traded on NASDAQ under the ticker symbol SRZN.
Who are Surrozen's investors?
Surrozen has 14 investors. Key investors include RA Capital, Hartford HealthCare, The Column Group, Venrock, and Access Biotechnology.
What is Surrozen's ticker symbol?
The ticker symbol of Surrozen is SRZN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.